Ismn Abz (Isosorbide Mononitrate)

Isosorbide Mononitrate acts as a long‑acting nitrate to relieve myocardial ischemia and improve exercise tolerance.

• Stable angina pectoris: reduces frequency and severity of chest‑pain episodes.
• Chronic heart failure (off‑label): may improve functional capacity and reduce symptom burden.
• Prevention of angina attacks: provides sustained nitrate therapy to lower myocardial oxygen demand.

• Isosorbide Mononitrate is metabolized to release nitric oxide, which activates guanylate cyclase in vascular smooth muscle. The resulting increase in cyclic GMP causes relaxation of arterial and venous vessels, producing vasodilation, reducing preload and afterload, and consequently lowering myocardial oxygen consumption.

Isosorbide Mononitrate may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Headache: throbbing pain often occurring after the first dose.
• Dizziness or light‑headedness: related to blood pressure lowering.
• Flushing: warm sensation, typically on the face or neck.
• Nausea: mild gastrointestinal upset.
• Hypotension: measurable drop in blood pressure, especially when standing.
• Palpitations: awareness of heartbeat irregularities.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure requiring medical attention.
• Syncope: fainting episodes due to inadequate cerebral perfusion.
• Myocardial infarction: rare but possible in susceptible individuals.
• Allergic reaction: rash, itching, swelling, or anaphylaxis.
• Methemoglobinemia: rare blood disorder causing reduced oxygen delivery.

Before initiating therapy, clinicians should evaluate cardiovascular status and consider potential interactions.

• Assess cardiovascular status: monitor blood pressure and heart rate prior to starting treatment.
• Avoid concurrent PDE‑5 inhibitors: risk of profound hypotension when combined with drugs such as sildenafil.
• Adjust dose in renal impairment: consider lower doses for patients with reduced kidney function.
• Educate patient on orthostatic dizziness: advise rising slowly from sitting or lying positions.
• Store at ambient temperature: keep in the original pack, protect from moisture.

Isosorbide Mononitrate can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

• Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil): may cause severe hypotension.
• Other nitrates (e.g., nitroglycerin, isosorbide dinitrate): additive vasodilatory effect leading to dangerous blood pressure drops.

Moderate Interactions (Monitor Closely)

• Antihypertensives (ACE inhibitors, beta‑blockers, calcium‑channel blockers): may enhance blood‑pressure‑lowering effects.
• Diuretics: can increase the risk of electrolyte imbalance and dehydration.
• Alcohol: may potentiate hypotensive action and cause dizziness.